Surgery versus cast immobilisation for adults with a bicortical fracture of the scaphoid waist (SWIFFT): a pragmatic, multicentre, open-label, randomised superiority trial.


Journal

Lancet (London, England)
ISSN: 1474-547X
Titre abrégé: Lancet
Pays: England
ID NLM: 2985213R

Informations de publication

Date de publication:
08 08 2020
Historique:
received: 10 02 2020
revised: 02 04 2020
accepted: 16 04 2020
entrez: 11 8 2020
pubmed: 11 8 2020
medline: 19 8 2020
Statut: ppublish

Résumé

Scaphoid fractures account for 90% of carpal fractures and occur predominantly in young men. The use of immediate surgical fixation to manage this type of fracture has increased, despite insufficient evidence of improved outcomes over non-surgical management. The SWIFFT trial compared the clinical effectiveness of surgical fixation with cast immobilisation and early fixation of fractures that fail to unite in adults with scaphoid waist fractures displaced by 2 mm or less. This pragmatic, parallel-group, multicentre, open-label, two-arm, randomised superiority trial included adults (aged 16 years or older) who presented to orthopaedic departments of 31 hospitals in England and Wales with a clear bicortical fracture of the scaphoid waist on radiographs. An independent remote randomisation service used a computer-generated allocation sequence with randomly varying block sizes to randomly assign participants (1:1) to receive either early surgical fixation (surgery group) or below-elbow cast immobilisation followed by immediate fixation if non-union of the fracture was confirmed (cast immobilisation group). Randomisation was stratified by whether or not there was displacement of either a step or a gap of 1-2 mm inclusive on any radiographic view. The primary outcome was the total patient-rated wrist evaluation (PRWE) score at 52 weeks after randomisation, and it was analysed on an available case intention-to-treat basis. This trial is registered with the ISRCTN registry, ISRCTN67901257, and is no longer recruiting, but long-term follow-up is ongoing. Between July 23, 2013, and July 26, 2016, 439 (42%) of 1047 assessed patients (mean age 33 years; 363 [83%] men) were randomly assigned to the surgery group (n=219) or to the cast immobilisation group (n=220). Of these, 408 (93%) participants were included in the primary analysis (203 participants in the surgery group and 205 participants in the cast immobilisation group). 16 participants in the surgery group and 15 participants in the cast immobilisation group were excluded because of either withdrawal, no response, or no follow-up data at 6, 12, 26, or 52 weeks. There was no significant difference in mean PRWE scores at 52 weeks between the surgery group (adjusted mean 11·9 [95% CI 9·2-14·5]) and the cast immobilisation group (14·0 [11·3 to 16·6]; adjusted mean difference -2·1 [95% CI -5·8 to 1·6], p=0·27). More participants in the surgery group (31 [14%] of 219 participants) had a potentially serious complication from surgery than in the cast immobilisation group (three [1%] of 220 participants), but fewer participants in the surgery group (five [2%]) had cast-related complications than in the cast immobilisation group (40 [18%]). The number of participants who had a medical complication was similar between the two groups (four [2%] in the surgery group and five [2%] in the cast immobilisation group). Adult patients with scaphoid waist fractures displaced by 2 mm or less should have initial cast immobilisation, and any suspected non-unions should be confirmed and immediately fixed with surgery. This treatment strategy will help to avoid the risks of surgery and mostly limit the use of surgery to fixing fractures that fail to unite. National Institute for Health Research Health Technology Assessment Programme.

Sections du résumé

BACKGROUND
Scaphoid fractures account for 90% of carpal fractures and occur predominantly in young men. The use of immediate surgical fixation to manage this type of fracture has increased, despite insufficient evidence of improved outcomes over non-surgical management. The SWIFFT trial compared the clinical effectiveness of surgical fixation with cast immobilisation and early fixation of fractures that fail to unite in adults with scaphoid waist fractures displaced by 2 mm or less.
METHODS
This pragmatic, parallel-group, multicentre, open-label, two-arm, randomised superiority trial included adults (aged 16 years or older) who presented to orthopaedic departments of 31 hospitals in England and Wales with a clear bicortical fracture of the scaphoid waist on radiographs. An independent remote randomisation service used a computer-generated allocation sequence with randomly varying block sizes to randomly assign participants (1:1) to receive either early surgical fixation (surgery group) or below-elbow cast immobilisation followed by immediate fixation if non-union of the fracture was confirmed (cast immobilisation group). Randomisation was stratified by whether or not there was displacement of either a step or a gap of 1-2 mm inclusive on any radiographic view. The primary outcome was the total patient-rated wrist evaluation (PRWE) score at 52 weeks after randomisation, and it was analysed on an available case intention-to-treat basis. This trial is registered with the ISRCTN registry, ISRCTN67901257, and is no longer recruiting, but long-term follow-up is ongoing.
FINDINGS
Between July 23, 2013, and July 26, 2016, 439 (42%) of 1047 assessed patients (mean age 33 years; 363 [83%] men) were randomly assigned to the surgery group (n=219) or to the cast immobilisation group (n=220). Of these, 408 (93%) participants were included in the primary analysis (203 participants in the surgery group and 205 participants in the cast immobilisation group). 16 participants in the surgery group and 15 participants in the cast immobilisation group were excluded because of either withdrawal, no response, or no follow-up data at 6, 12, 26, or 52 weeks. There was no significant difference in mean PRWE scores at 52 weeks between the surgery group (adjusted mean 11·9 [95% CI 9·2-14·5]) and the cast immobilisation group (14·0 [11·3 to 16·6]; adjusted mean difference -2·1 [95% CI -5·8 to 1·6], p=0·27). More participants in the surgery group (31 [14%] of 219 participants) had a potentially serious complication from surgery than in the cast immobilisation group (three [1%] of 220 participants), but fewer participants in the surgery group (five [2%]) had cast-related complications than in the cast immobilisation group (40 [18%]). The number of participants who had a medical complication was similar between the two groups (four [2%] in the surgery group and five [2%] in the cast immobilisation group).
INTERPRETATION
Adult patients with scaphoid waist fractures displaced by 2 mm or less should have initial cast immobilisation, and any suspected non-unions should be confirmed and immediately fixed with surgery. This treatment strategy will help to avoid the risks of surgery and mostly limit the use of surgery to fixing fractures that fail to unite.
FUNDING
National Institute for Health Research Health Technology Assessment Programme.

Identifiants

pubmed: 32771106
pii: S0140-6736(20)30931-4
doi: 10.1016/S0140-6736(20)30931-4
pii:
doi:

Types de publication

Journal Article Multicenter Study Pragmatic Clinical Trial Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

390-401

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

Copyright © 2020 Elsevier Ltd. All rights reserved.

Auteurs

Joseph J Dias (JJ)

Leicester General Hospital, University Hospitals of Leicester National Health Service (NHS) Trust, Leicester, UK. Electronic address: jd96@le.ac.uk.

Stephen D Brealey (SD)

York Trials Unit, Department of Health Sciences, University of York, York, UK.

Caroline Fairhurst (C)

York Trials Unit, Department of Health Sciences, University of York, York, UK.

Rouin Amirfeyz (R)

University Hospitals Bristol NHS Foundation Trust, Bristol Royal Infirmary, Bristol, UK.

Bhaskar Bhowal (B)

Leicester General Hospital, University Hospitals of Leicester National Health Service (NHS) Trust, Leicester, UK.

Neil Blewitt (N)

North Bristol NHS Trust, Southmead Hospital, Bristol, UK.

Mark Brewster (M)

University Hospitals Birmingham NHS Foundation Trust, Queen Elizabeth Hospital, Birmingham, UK.

Daniel Brown (D)

The Royal Liverpool and Broadgreen University Hospitals NHS Trust, Royal Liverpool University Hospital, Liverpool, UK.

Surabhi Choudhary (S)

University Hospitals Birmingham NHS Foundation Trust, Queen Elizabeth Hospital, Birmingham, UK.

Christopher Coapes (C)

South Tees Hospitals NHS Foundation Trust, The James Cook University Hospital, Middlesbrough, UK.

Liz Cook (L)

York Trials Unit, Department of Health Sciences, University of York, York, UK.

Matthew Costa (M)

The Kadoorie Centre, John Radcliffe Hospital, Oxford, UK; Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Nuffield Orthopaedic Centre, Oxford, UK.

Tim Davis (T)

Nottingham University Hospitals NHS Trust, Queen's Medical Centre Campus, Nottingham, UK.

Livio Di Mascio (L)

Barts Health NHS Trust, The Royal London Hospital, London, UK.

Grey Giddins (G)

Royal United Hospital Bath NHS Trust, Royal United Hospital, Bath, UK.

Helen Hedley (H)

University Hospitals Coventry and Warwickshire NHS Trust, University Hospital, Coventry, UK.

Catherine Hewitt (C)

York Trials Unit, Department of Health Sciences, University of York, York, UK.

Sebastian Hinde (S)

Centre for Health Economics, University of York, York, UK.

Jonathan Hobby (J)

Hampshire Hospitals NHS Foundation Trust, Basingstoke and North Hampshire Hospital, Basingstoke, UK.

Stephen Hodgson (S)

Bolton NHS Foundation Trust, Royal Bolton Hospital, Bolton, UK.

Laura Jefferson (L)

Department of Health Sciences, University of York, York, UK.

Kanagaratnam Jeyapalan (K)

Leicester General Hospital, University Hospitals of Leicester National Health Service (NHS) Trust, Leicester, UK.

Phillip Johnston (P)

Cambridge University Hospitals NHS Foundation Trust, Addenbrooke's Hospital, Cambridge, UK.

Jonathon Jones (J)

Peterborough and Stamford Hospitals NHS Foundation Trust, Peterborough City Hospital, Peterborough, UK.

Ada Keding (A)

York Trials Unit, Department of Health Sciences, University of York, York, UK.

Paul Leighton (P)

School of Medicine, University of Nottingham, Queen's Medical Centre, Nottingham, UK.

Andrew Logan (A)

Cardiff and Vale University of Health Board, University Hospital of Wales, Cardiff, UK.

Will Mason (W)

Gloucestershire Hospitals NHS Foundation Trust, Gloucestershire Royal Hospital, Gloucester, UK.

Andrew McAndrew (A)

Royal Berkshire NHS Foundation Trust, Royal Berkshire Hospital, Reading, UK.

Ian McNab (I)

Oxford University Hospitals NHS Trust, Nuffield Orthopaedic Centre, Oxford, UK.

Lindsay Muir (L)

Salford Royal Hospital NHS Foundation Trust, Salford, UK.

James Nicholl (J)

Maidstone and Tunbridge Wells NHS Trust, Tunbridge Wells, Kent, UK.

Matthew Northgraves (M)

Hull Health Trials Unit, University of Hull, Hull, UK.

Jared Palmer (J)

Leicester General Hospital, University Hospitals of Leicester National Health Service (NHS) Trust, Leicester, UK.

Rob Poulter (R)

Royal Cornwall Hospitals NHS Trust, Royal Cornwall Hospital, Truro, Cornwall, UK.

Zulfi Rahimtoola (Z)

Royal Berkshire NHS Foundation Trust, Royal Berkshire Hospital, Reading, UK.

Amar Rangan (A)

York Trials Unit, Department of Health Sciences, University of York, York, UK; Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Nuffield Orthopaedic Centre, Oxford, UK.

Simon Richards (S)

Poole Hospital NHS Foundation Trust, Poole, Dorset, UK.

Gerry Richardson (G)

Centre for Health Economics, University of York, York, UK.

Paul Stuart (P)

Newcastle upon Tyne Hospitals NHS Foundation Trust, Royal Victoria Infirmary, Newcastle upon Tyne, UK.

Nicholas Taub (N)

Department of Health Sciences, University of Leicester, George Davies Centre, Leicester, UK.

Adel Tavakkolizadeh (A)

King's College Hospital NHS Foundation Trust, King's College Hospital, Brixton, London, UK.

Garry Tew (G)

Department of Sport, Exercise and Rehabilitation, Northumbria University, Newcastle upon Tyne, UK.

John Thompson (J)

Department of Health Sciences, University of Leicester, George Davies Centre, Leicester, UK.

David Torgerson (D)

York Trials Unit, Department of Health Sciences, University of York, York, UK.

David Warwick (D)

University Hospital Southampton NHS Foundation Trust, Southampton General Hospital, Southampton, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH